Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
148.03%
-
Total 13F principal
-
$403,261,935
-
Principal change
-
+$79,738,163
-
Total reported market value
-
$598,778,599
-
Number of holders
-
45
-
Value change
-
+$119,871,332
-
Number of buys
-
20
-
Number of sells
-
21
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2015
As of 31 Mar 2015,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
45 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$403,261,935
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, Lombard Odier Asset Management (Europe) Ltd, MACKAY SHIELDS LLC, AXA, VICTORY CAPITAL MANAGEMENT INC, Invesco Ltd., ADVENT CAPITAL MANAGEMENT /DE/, PRUDENTIAL PLC, BlueMountain Capital Management, LLC, and Thrivent Financial for Lutherans.
This page lists
45
institutional bondholders reporting positions
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.